Marshall Financial Group LLC Acquires 15,422 Shares of Relx Plc $RELX

Key Points

• Marshall Financial Group LLC increased its stake in Relx Plc by 207.4% during Q2, owning 22,859 shares valued at approximately $1.22 million.
• Relx recently cut its dividend to $0.2634 per share, resulting in a dividend yield of 170.0% and a payout ratio of 28.49%.
• While Morgan Stanley maintained an "overweight" rating on Relx, Wall Street Zen downgraded the stock from a "buy" to a "hold" rating, indicating mixed sentiment among analysts.

Marshall Financial Group LLC lifted its position in Relx Plc (NYSE:RELX - Free Report) by 207.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,859 shares of the technology company's stock after buying an additional 15,422 shares during the quarter. Marshall Financial Group LLC's holdings in Relx were worth $1,222,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. ABC Arbitrage SA grew its stake in shares of Relx by 40.1% in the first quarter. ABC Arbitrage SA now owns 194,197 shares of the technology company's stock valued at $9,789,000 after buying an additional 55,579 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Relx by 16.5% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 167,175 shares of the technology company's stock valued at $8,427,000 after purchasing an additional 23,692 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in Relx by 4.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 4,072,342 shares of the technology company's stock valued at $205,287,000 after purchasing an additional 173,976 shares during the last quarter. Pandora Wealth Inc. acquired a new stake in Relx during the 1st quarter valued at $757,000. Finally, Massachusetts Financial Services Co. MA lifted its holdings in Relx by 103.7% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 106,220 shares of the technology company's stock valued at $5,355,000 after purchasing an additional 54,062 shares during the last quarter. 15.02% of the stock is owned by institutional investors.

Relx Price Performance

RELX stock traded down $0.04 during midday trading on Monday, reaching $46.99. The company had a trading volume of 402,991 shares, compared to its average volume of 943,797. The company has a market capitalization of $86.11 billion, a price-to-earnings ratio of 25.27, a price-to-earnings-growth ratio of 3.07 and a beta of 0.87. The stock has a 50 day moving average price of $49.14 and a 200-day moving average price of $51.09. Relx Plc has a 1-year low of $44.19 and a 1-year high of $56.33. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42.

Relx Cuts Dividend

The firm also recently announced a semi-annual dividend, which was paid on Tuesday, September 16th. Shareholders of record on Friday, August 8th were given a $0.2634 dividend. This represents a yield of 170.0%. The ex-dividend date was Friday, August 8th. Relx's payout ratio is currently 27.96%.

Analysts Set New Price Targets

Several brokerages have issued reports on RELX. Wall Street Zen downgraded Relx from a "buy" rating to a "hold" rating in a report on Friday, September 5th. Kepler Capital Markets raised Relx from a "hold" rating to a "strong-buy" rating in a report on Thursday. Finally, Morgan Stanley reissued an "overweight" rating on shares of Relx in a report on Thursday, September 11th. One equities research analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the stock. Based on data from MarketBeat.com, Relx currently has a consensus rating of "Buy".

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.